Document Detail


Preparation of sustained-release dosage form of Venlafaxine HCl using liquisolid technique.
MedLine Citation:
PMID:  23347382     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CONTEXT: The aim of this study is to control the dissolution rate of Venlafaxine HCl.
OBJECTIVE: To prepare sustained release tablets of Venlafaxine HCl.
MATERIAL AND METHODS: Different liquisolid formulations, liquid vehicles, drug concentration in the liquid medication and different ratios of carrier to coating material (R) were prepared. The prepared powders were characterized for possible interactions between drug and excipients using differential scanning calorimetry, X-ray, Fourier transform infrared analysis and scanning electron microscopy. Powder flowability was also evaluated, then they are compressed at different compression forces, and the compressed tablets were evaluated for their mechanical properties and dissolution profile.
RESULTS: Release results show that sustained release behavior can be obtained from liquisolid formulation containing Tween 80 as liquid vehicle.
DISCUSSION: Many factors affect the retardation effect of Venlafaxine HCl such as the type of liquid vehicle, drug concentration in the liquid medication and R. The mechanism of the in vitro release profiles was found to be mainly controlled by diffusion and polymer relaxation.
CONCLUSION: Sustained release formulation of Venlafaxine HCl was attained using the liquisolid technique.
Authors:
M Khanfar; M Sheikh Salem; Faiza Kaddour
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2013-01-24
Journal Detail:
Title:  Pharmaceutical development and technology     Volume:  19     ISSN:  1097-9867     ISO Abbreviation:  Pharm Dev Technol     Publication Date:  2014 Feb 
Date Detail:
Created Date:  2013-12-10     Completed Date:  2014-07-14     Revised Date:  2014-07-31    
Medline Journal Info:
Nlm Unique ID:  9610932     Medline TA:  Pharm Dev Technol     Country:  England    
Other Details:
Languages:  eng     Pagination:  103-15     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antidepressive Agents, Second-Generation / administration & dosage*
Cyclohexanols / administration & dosage*
Delayed-Action Preparations / chemistry*
Excipients / chemistry
Polysorbates / chemistry
Powders
Solubility
Chemical
Reg. No./Substance:
0/Antidepressive Agents, Second-Generation; 0/Cyclohexanols; 0/Delayed-Action Preparations; 0/Excipients; 0/Polysorbates; 0/Powders; GRZ5RCB1QG/venlafaxine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Characteristics of Porphyromonas gingivalis lipopolysaccharide in co-culture with Fusobacterium nucl...
Next Document:  The effects of a stimulating intron on the expression of heterologous genes in Arabidopsis thaliana.